Knight Therapeutics Inc SEC EDGAR Filings (CIK 0001756235)

SEC EDGAR filings, ownership reports, and insider transactions for Knight Therapeutics Inc.

Business address
3400 Boulevard De Maisonneuve West, Suite 1055, Montreal, Quebec, Canada, H3Z 3B8
Top holdings (ownership)
SYNR and SXTP
Top holdings (Schedule 13G)
SNYR
State of incorporation
Quebec, Canada
Fiscal year end
31 December
⭐ Add to watchlist ⭐
Get insider transactions for this reporting owner
Knight Therapeutics Inc has filed 9 SEC EDGAR filings since 17 Oct 2018

Latest Filings

Recent SEC filings for Knight Therapeutics Inc including SCHEDULE 13G/A, 4, SCHEDULE 13G and more.

Form type Document Filing Description Filing date Reporting date File number(s)
SCHEDULE 13G/A Open SCHEDULE 13G/A document View SEC filing for SCHEDULE 13G/A 13 Jun 2025
4 Open 4 document View SEC filing for 4 13 Jun 2025 11 Jun 2025 001-42374
SCHEDULE 13G Open SCHEDULE 13G document View SEC filing for SCHEDULE 13G 20 Mar 2025
SC 13G/A Open SC 13G/A document View SEC filing for SC 13G/A AMENDMENT NO. 2 TO SCHEDULE 13G 13 Nov 2024
3 Open 3 document View SEC filing for 3 PRIMARY DOCUMENT 22 Oct 2024 22 Oct 2024 001-42374
4 Open 4 document View SEC filing for 4 FORM 4 03 Apr 2024 28 Jul 2023 001-41719
3 Open 3 document View SEC filing for 3 18 Dec 2023 11 Jul 2023 001-41719
SC 13G/A Open SC 13G/A document View SEC filing for SC 13G/A SC 13G/A 14 Feb 2019
SC 13G Open SC 13G document View SEC filing for SC 13G SCHEDULE 13G 17 Oct 2018

About this filer

Knight Therapeutics Inc files with the SEC under CIK 0001756235. This page aggregates EDGAR filings and related ownership activity.

See reporting owner transactions.

FAQ

What is a CIK?
A Central Index Key (CIK) is a unique identifier assigned by the SEC to each filer.
Why are some filings missing?
New filings appear as the SEC updates EDGAR, and older records can vary by availability.
How often is this page updated?
Updates follow new EDGAR submissions and periodic data refreshes.

Related pages